🇺🇸 Dorzolamide Hcl 2% Oph Soln in United States

FDA authorised Dorzolamide Hcl 2% Oph Soln on 1 April 1998

Marketing authorisations

FDA — authorised 1 April 1998

  • Application: NDA020816
  • Marketing authorisation holder: SANDOZ
  • Local brand name: AZOPT
  • Indication: SUSPENSION/DROPS — OPHTHALMIC
  • Status: approved

Read official source →

FDA

  • Status: approved

Dorzolamide Hcl 2% Oph Soln in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dorzolamide Hcl 2% Oph Soln approved in United States?

Yes. FDA authorised it on 1 April 1998; FDA has authorised it.

Who is the marketing authorisation holder for Dorzolamide Hcl 2% Oph Soln in United States?

SANDOZ holds the US marketing authorisation.